Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

Notice of Intent to Sole Source-Hamilton Company

Active
JA26-06-12Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The Defense Health Agency Contracting Activity at Fort Detrick, Maryland, intends to negotiate a sole source contract with Hamilton Company for the purchase, delivery, installation, and extended warranty of one Hamilton Microlab STAR Vantage 2.0 robotic workstation. This state-of-the-art equipment is required to replace an existing Hamilton STARLET robotic workstation that has reached its end-of-life status. The robotic workstation, along with its computers and software, is essential for supporting the Armed Forces Medical Examiner System’s DNA Operations by facilitating high-throughput DNA testing to identify U.S. Service members through advanced laboratory techniques such as extraction, amplification, and sequencing. These operations are carried out in accordance with specific U.S. legal mandates and Department of Defense regulations. Hamilton Company is recognized as the sole manufacturer and authorized reseller of the Hamilton Microlab STAR Vantage 2.0, which is the latest model in its product line and fully compatible with existing systems. This acquisition will be conducted using simplified acquisition procedures without set-aside restrictions and is classified under NAICS code 334516. Although no formal solicitation exists, the agency has issued a presolicitation notice inviting interested parties to submit technical and cost capability statements by June 29, 2026. The Government retains discretion over whether to engage in competitive procurement based on the responses received. Correspondence should be directed via email to the designated points of contact, with no phone calls accepted. The performance location is Dover Air Force Base, Delaware.

General Info

Sole source contract with Hamilton for robotic workstation upgrade supporting DNA testing at Dover AFB.

Agency

Department Of Defense → Defense Health Agency

NAICS

334516 - Analytical Laboratory Instrument Manufacturing View NAICS

Place of Performance

Dover AFB, DE, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhasePresolicitation
Posted

Presolicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Organization / Agency
Department Of Defense → Defense Health Agency
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Kasey Carroll
Courtney Piar

Full Description

Show more


 The Defense Health Agency Contracting Activity (DHACA) in Fort Detrick, MD intends to negotiate on a sole source basis (IAW RFO 12.102(a)) with Hamilton Company, 4970 Energy way Reno, NV 89502 as the only responsible source that can purchase, delivery, installation, and extended warranty of one (1) Hamilton Microlab STAR Vantage 2.0 robots. This is a Presolicitation notice in accordance with RFO 5.101.


Hamilton Company is the only company that can purchase, delivery, installation, and extended warranty of one (1) Hamilton Microlab STAR Vantage 2.0 robotic workstation to replace an existing Hamilton STARLET robotic workstation that is End-of-Life (EOL). The required Hamilton Microlab STAR robotic workstations, computers and software are used to support AFMES- DNA OPS mission of assisting Armed Forces Medical Examiner System (AFMES) and the Defense POW/MIA Accounting Agency (DPAA),  with human remains Deoxyribonucleic Acid (DNA) testing for the identification of United States (US) Service members as mandated under title 10 USC, chapter 75, 1471 and 10 USC, Chapter 76, 1501-1513; NDAA 2010, Section 541 (d)(2) and DODI 5154.30. AFMES-DNA OPS requires the highly specialized Hamilton Microlab STAR liquid handling robots, computers and software for high throughput extraction, short tandem repeat amplification, and next generation sequencing of military DNA references and Family Reference specimens used to identify unknown human remains. AFMES-DNA OPS requires that the Hamilton Microlab STAR Vantage 2.0 provide optimal performance and that the variation between robots in the Hamilton Microlab STAR family of instruments are made using Good Laboratory Practices (GLP) / Good Manufacturing Practices (GMP) and that programs between the STAR Plus and STAR Vantage 2.0 are compatible.



Hamilton is the sole manufacturer and reseller of the Hamilton Microlab STAR Vantage 2.0 robotic workstation listed in this document. The Hamilton Microlab STAR Vantage 2.0 is the newest model in the Hamilton Microlab STAR suite of robots and is replacing the older Hamilton STARLET.


This acquisition is being conducted under simplified acquisition procedures. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 334516 with a Small Business Size Standard of 3,000 employees. This presolicitation notice is not a request for competitive proposals and no solicitation document exists for this requirement. However, any parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same service. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct competitive procurement.


Submit email capability statements (using PDF, MS Word, Excel attachments) to Kasey Carroll at Kasey.l.carroll.civ@health.mil. Statements are due no later than 10:00 A.M. EST on 29 June 2026. No phone calls will be accepted.

Similar Contracts

NAICS: 334516
New
Federal
Protective Clothing Blood Penetration Resistance TesterThe U.S. Food and Drug Administration’s Center for Devices and Radiological Health is conducting a market research effort to identify small businesses capable of supplying a Protective Clothing Blood Penetration Resistance Tester. This device is intended to automate and improve the testing of level 4 medical gowns for viral penetration resistance, significantly reducing manual testing time while enhancing consistency and repeatability. The instrument must meet several technical specifications, including the ability to run four simultaneous tests, automatic timing functions, real-time pressure monitoring, and compliance with ASTM F1670 and ASTM F1671 standards. The system must be new, turn-key, and include all necessary hardware, software, manuals, installation, training, and qualification documentation. Interested firms, particularly small businesses under NAICS code 334516, are invited to submit capability statements by June 23, 2026. Responses should include detailed company information, past performance data, technical compliance evidence, warranty terms, and manufacturing origin to facilitate evaluation under Buy American requirements. The delivery location is the FDA’s Winchester Engineering and Analytical Center in Massachusetts, with delivery expected within 120 days of award. This announcement does not constitute a solicitation or binding contract but serves as an information-gathering step for potential future procurements.
FDA Office Of Acq Grant Svcs

POSTED

1 day ago

DEADLINE

in 7 days
View Details
NAICS: 334516
New
Federal
FY26 Lab Consolidation for Coagulation CPRR EffortThe contract solicits a comprehensive Cost Per Reportable Result (CPRR) agreement to supply and support coagulation analyzers for multiple Military Treatment Facilities (MTFs) under the Defense Health Agency HCD West. Spanning one base year with four option years, the contract encompasses all aspects necessary for effective coagulation testing, including the provision of coagulation analyzer equipment, reagents, consumables, controls, peripherals such as printers and uninterrupted power supplies, and all parts needed to ensure proper instrument operation. The CPRR price covers every element required to generate a single patient reportable result, including dilution, repeat and confirmatory testing, as well as quality control and calibration per Clinical Laboratory Standards Institute guidelines. The contractor is responsible for delivery, installation, removal, preventive maintenance, repairs, and ensuring continuous, uninterrupted analyzer operation even in cases of interface failures with laboratory information systems or electronic health records. In addition to equipment and consumables, the contract requires comprehensive training for government personnel, offering user-level and advanced super-user training sessions at both the installation sites and contractor facilities, with contractor-borne travel expenses for the latter. The analyzers must be new, FDA-approved, and capable of seamless bidirectional interfacing with existing Department of Defense electronic health records and laboratory management systems. The scope also includes managing hazardous waste generated during testing and accommodating varying workload volumes, surge capacity, and volume adjustments at different MTFs. Detailed site-specific data informs equipment deployment, covering delivery schedules, physical requirements, power needs, and anticipated test volumes for various coagulation assays such as Prothrombin Time and Activated Partial Thromboplastin Time. The contractor is tasked with providing ongoing operational and technical support, monthly reporting, and ensuring overall performance quality throughout the contract term.
Defense Health Agency Hcd West

POSTED

1 day ago

DEADLINE

in 9 days
View Details